纤维素纤维素原降解产品与比的预测价值,用于动脉瘤下关节出血患者的功能不良结果:一项回顾性病例对照研究

Weida Li1,2,3, Shuangquan Zhao3,4, Xinlong Chen1,2

  • 1Department of Neurosurgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.

Neurocritical care
|October 13, 2023
PubMed
概括

纤维素降解产物与的比率 (FPR) 有效地预测了动脉瘤下关节出血 (aSAH) 患者的不良结果. 较高的FPR水平表明aSAH后不良功能预后的风险更大.